HemoCue AB Box 1204 262 23 Ängelholm SWEDEN   Phone: +46 77 570 02 10 Fax: +46 77 570 02 12 E-mail: info@hemocue.se    Contact in your country    Online Privacy Policy    Printer friendly	Hemoglobin is used to monitor and manage anemia in dialysis patients. By using the HemoCue Hemoglobin system, information about the patient’s anemia status can be obtained in more timely manner, and thus medical care can be initiated sooner. Point-of-care testing using the HemoCue system can also facilitate more appropriate EPO dosages and has been proven to be much more accurate than something like the hematocrit method.